Data / Drug companies / Morepen Laboratories Limited
Morepen Laboratories Limited: 10 products in the FDA NDC directory, labeler code 62993
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Morepen Laboratories Limited (labeler code 62993) lists 10 products in the FDA National Drug Code Directory, covering 2 finished drugs by generic name. By type: 8 bulk ingredients, 2 over the counter drugs. Its main marketing category is bulk ingredients. The newest product started marketing on May 25, 2026.
The request: Watch Morepen Laboratories Limited (FDA labeler code 62993): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 62993
- Products in commercial distribution
- 10
- Packages
- 20
- Finished drugs by generic name
- 2
- Prescription products
- 0
- Over the counter products
- 2
- Flagged as original packager
- 2 of 2 products that carry the flag
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- December 19, 1996
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 8 | 80% |
| Over the counter monograph drugs | 2 | 20% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 8 | 80% |
| Over the counter drugs | 2 | 20% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Sennosides | 1 | 65 |
| Docusate sodium and sennosides | 1 | 29 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 8 | 80% |
| Tablet | 2 | 20% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ertugliflozin l-pyroglutamate | 62993-0810 | Powder | Bulk ingredients | May 25, 2026 |
| Docusate Sodium and Sennosides | 62993-0002 | Tablet | Over the counter monograph drugs | October 1, 2025 |
| Sennosides | 62993-0001 | Tablet | Over the counter monograph drugs | October 1, 2025 |
| Fexofenadine hydrochloride | 62993-0809 | Powder | Bulk ingredients | January 15, 2020 |
| Linagliptin | 62993-0808 | Powder | Bulk ingredients | March 28, 2019 |
| Montelukast sodium | 62993-0807 | Powder | Bulk ingredients | September 19, 2012 |
| Montelukast sodium | 62993-0806 | Powder | Bulk ingredients | September 19, 2012 |
| Desloratadine | 62993-0805 | Powder | Bulk ingredients | August 11, 2004 |
| Loratadine | 62993-0803 | Powder | Bulk ingredients | November 20, 2000 |
| Loratadine | 62993-0801 | Powder | Bulk ingredients | December 19, 1996 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.